“…In endometrial cancer cell lines urolithin A obtained from black raspberries was found particularly effective in suppressing cell proliferation in a time-and dose-dependent manner, arresting the G2/M phase of the cell cycle and modulating ERa-dependent gene expression, thereby inhibiting endometrial cancer proliferation (Zhang et al, 2016). Raspberry extracts promoted anticancer activities also in human ovarian carcinoma (Kim et al, 2016, Lee et al, 2016aLee et al, 2016b), breast (Wang et al, 2013;Zhang et al, 2015;Wang, Zhu, and Marcone 2015;Ljevar et al, 2016;Park et al, 2017) and cervical cancer cells (Saini et al, 2014;Ljevar et al, 2016) as demonstrated by the reduction in cell viability and promotion of apoptotic and cytotoxic processes. Interesting results were also obtained in vulvar squamous cell carcinoma cell line, where black raspberry extract treatment efficiently upregulated caspase-14 level, suggesting its possible use in topical treatment of vulvar lesions (Joehlin-Price et al, 2014).…”